A 24‐month metformin treatment study of children with obesity: Changes in circulating GDF ‐15 and associations with changes in body weight and visceral fat-Reference-Cited by-同舟云学术

A 24‐month metformin treatment study of children with obesity: Changes in circulating GDF ‐15 and associations with changes in body weight and visceral fat

Published:2021-08-23 Issue:2 Volume:17 Page:
ISSN:2047-6302
Container-title:Pediatric Obesity
language:en
Short-container-title:Pediatric Obesity

Author:

Carreras‐Badosa Gemma¹^ORCID,Gómez‐Vilarrubla Ariadna²,Mas‐Parés Berta¹,Martínez‐Calcerrada José‐María²,Xargay‐Torrent Silvia¹,Prats‐Puig Anna³,Puerto‐Carranza Elsa¹⁴,Díaz‐Roldán Ferran¹,Zegher Francis⁵,Ibañez Lourdes⁶⁷,Bassols Judit²^ORCID,López‐Bermejo Abel¹⁴⁸^ORCID

Affiliation:

1. Pediatric Endocrinology Group Girona Biomedical Research Institute Girona Spain

2. Maternal‐Fetal Metabolic Group Girona Biomedical Research Institute Girona Spain

3. University School of Health and Sport (EUSES) University of Girona Girona Spain

4. Pediatrics Dr. Josep Trueta Hospital Girona Spain

5. Department of Development & Regeneration University of Leuven Leuven Belgium

6. Sant Joan de Déu Children's Hospital Pediatric Institute University of Barcelona Barcelona Spain

7. CIBERDEM Instituto de Salud Carlos III Madrid Spain

8. Department of Medical Sciences University of Girona Girona Spain

Funder

European Regional Development Fund

Publisher

Wiley

Subject

Public Health, Environmental and Occupational Health,Nutrition and Dietetics,Health Policy,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijpo.12845

Reference19 articles.

1. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

2. Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood

3. Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion

4. Drug interventions for the treatment of obesity in children and adolescents;Mead E;Cochrane Datab Syst Rev,2016

5. Pharmacotherapy of type 2 diabetes: An update

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21;2024-08-19

2. Overview of growth differentiation factor 15 (GDF15) in metabolic diseases;Biomedicine & Pharmacotherapy;2024-07

3. Update on Pediatric Anti-obesity Medications—Current Landscape and Approach to Prescribing;Current Obesity Reports;2024-04-30

4. Metformin and the Liver: Unlocking the Full Therapeutic Potential;Metabolites;2024-03-25

5. Metformin Protects Against Acute Kidney Injury Induced by Lipopolysaccharide via Up-Regulating the MCPIP1/SIRT1 Pathway;Biochemical Genetics;2024-02-12